Kohmann Bosshard Financial Services LLC Purchases Shares of 492 Albemarle Co. (NYSE:ALB)

Kohmann Bosshard Financial Services LLC acquired a new stake in shares of Albemarle Co. (NYSE:ALBFree Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 492 shares of the specialty chemicals company’s stock, valued at approximately $42,000.

Other large investors have also made changes to their positions in the company. Quarry LP raised its position in shares of Albemarle by 1,400.0% during the third quarter. Quarry LP now owns 270 shares of the specialty chemicals company’s stock valued at $26,000 after buying an additional 252 shares during the last quarter. Trust Co. of Vermont raised its position in shares of Albemarle by 606.5% during the fourth quarter. Trust Co. of Vermont now owns 325 shares of the specialty chemicals company’s stock valued at $28,000 after buying an additional 279 shares during the last quarter. First Community Trust NA raised its position in shares of Albemarle by 55.0% during the fourth quarter. First Community Trust NA now owns 400 shares of the specialty chemicals company’s stock valued at $34,000 after buying an additional 142 shares during the last quarter. Ameliora Wealth Management Ltd. acquired a new position in shares of Albemarle during the fourth quarter valued at about $35,000. Finally, MassMutual Private Wealth & Trust FSB raised its position in shares of Albemarle by 48.9% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 414 shares of the specialty chemicals company’s stock valued at $36,000 after buying an additional 136 shares during the last quarter. Institutional investors and hedge funds own 92.87% of the company’s stock.

Analysts Set New Price Targets

ALB has been the subject of a number of research analyst reports. Truist Financial cut their price objective on shares of Albemarle from $96.00 to $85.00 and set a “hold” rating for the company in a research report on Friday, February 14th. Morgan Stanley dropped their price target on shares of Albemarle from $73.00 to $68.00 and set an “underweight” rating for the company in a research report on Tuesday, February 18th. Deutsche Bank Aktiengesellschaft dropped their price target on shares of Albemarle from $109.00 to $105.00 in a research report on Wednesday, February 12th. Clarkson Capital began coverage on shares of Albemarle in a research report on Tuesday, January 14th. They issued a “buy” rating and a $112.00 price target for the company. Finally, Robert W. Baird dropped their price target on shares of Albemarle from $103.00 to $92.00 and set a “neutral” rating for the company in a research report on Wednesday, February 12th. Two equities research analysts have rated the stock with a sell rating, fourteen have given a hold rating and six have given a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $109.68.

Get Our Latest Analysis on Albemarle

Insider Transactions at Albemarle

In other news, CEO J Kent Masters sold 2,525 shares of the business’s stock in a transaction on Thursday, December 5th. The stock was sold at an average price of $101.12, for a total transaction of $255,328.00. Following the completion of the sale, the chief executive officer now owns 73,747 shares in the company, valued at $7,457,296.64. The trade was a 3.31 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 0.38% of the stock is currently owned by corporate insiders.

Albemarle Stock Down 9.2 %

NYSE:ALB opened at $69.93 on Tuesday. The company has a market cap of $8.22 billion, a price-to-earnings ratio of -6.24 and a beta of 1.59. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.19 and a current ratio of 1.95. The stock’s fifty day moving average price is $85.10 and its two-hundred day moving average price is $92.19. Albemarle Co. has a 52-week low of $69.81 and a 52-week high of $140.22.

Albemarle (NYSE:ALBGet Free Report) last released its earnings results on Wednesday, February 12th. The specialty chemicals company reported ($1.09) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.60) by ($0.49). Albemarle had a negative return on equity of 1.72% and a negative net margin of 21.93%. On average, analysts anticipate that Albemarle Co. will post -0.04 EPS for the current year.

Albemarle Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, April 1st. Stockholders of record on Friday, March 14th will be given a dividend of $0.405 per share. The ex-dividend date of this dividend is Friday, March 14th. This represents a $1.62 dividend on an annualized basis and a dividend yield of 2.32%. Albemarle’s payout ratio is currently -14.46%.

Albemarle Profile

(Free Report)

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.

Recommended Stories

Want to see what other hedge funds are holding ALB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Albemarle Co. (NYSE:ALBFree Report).

Institutional Ownership by Quarter for Albemarle (NYSE:ALB)

Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.